Newbridge Financial Services Group, Inc. Atossa Therapeutics, Inc. Transaction History

Newbridge Financial Services Group, Inc.

  • $372 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022
SELL
$1.6 - $3.27 $48,000 - $98,100
-30,000 Reduced 93.75%
2,000 $3,000
Q3 2021

Oct 27, 2021
BUY
$2.89 - $6.4 $92,480 - $204,800
32,000 New
32,000 $104,000
Q2 2021

Sep 07, 2021
SELL
$1.52 - $8.62 $10,640 - $60,339
-7,000 Closed
0 $0
Q1 2021

Sep 07, 2021
BUY
$0.92 - $4.33 $6,440 - $30,310
7,000 New
7,000 $15,000

Others Institutions Holding ATOS

# of Institutions
90
Shares Held
29M
Call Options Held
39.8K
Put Options Held
90.9K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $105M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email